AP2523A - Self-assembling amphiphilic polymers as antiviral agents - Google Patents
Self-assembling amphiphilic polymers as antiviral agentsInfo
- Publication number
- AP2523A AP2523A AP2009004861A AP2009004861A AP2523A AP 2523 A AP2523 A AP 2523A AP 2009004861 A AP2009004861 A AP 2009004861A AP 2009004861 A AP2009004861 A AP 2009004861A AP 2523 A AP2523 A AP 2523A
- Authority
- AP
- ARIPO
- Prior art keywords
- self
- antiviral agents
- amphiphilic polymers
- assembling amphiphilic
- assembling
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6839—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting material from viruses
- A61K47/6841—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting material from viruses the antibody targeting a RNA virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G23/00—Compounds of titanium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Manufacturing & Machinery (AREA)
- Pulmonology (AREA)
- Environmental & Geological Engineering (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyethers (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/001607 WO2008091246A1 (en) | 2007-01-22 | 2007-01-22 | Self-assembling amphiphilic polymers as antiviral agents |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2009004861A0 AP2009004861A0 (en) | 2009-06-30 |
AP2523A true AP2523A (en) | 2012-11-30 |
Family
ID=39644738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2009004861A AP2523A (en) | 2007-01-22 | 2007-01-22 | Self-assembling amphiphilic polymers as antiviral agents |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100008938A1 (de) |
EP (1) | EP2120974B1 (de) |
JP (1) | JP5539733B2 (de) |
KR (1) | KR101405764B1 (de) |
CN (1) | CN101636169B (de) |
AP (1) | AP2523A (de) |
AU (1) | AU2007344657B9 (de) |
BR (1) | BRPI0719561A2 (de) |
CA (1) | CA2676239C (de) |
EA (1) | EA026125B1 (de) |
HU (1) | HUE034416T2 (de) |
IL (1) | IL198850A (de) |
MX (1) | MX2009005345A (de) |
NZ (1) | NZ576948A (de) |
WO (1) | WO2008091246A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001244567B2 (en) * | 2001-03-27 | 2006-04-27 | National Institute Of Agrobiological Sciences | Vegetative growth-specific promoter and genetically modified plants obtained thereby |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX341715B (es) * | 2007-07-19 | 2016-08-23 | Allexcel Inc | Polímeros anfifílicos de autoensamblaje como agentes anticáncer. |
US9119866B2 (en) | 2008-04-08 | 2015-09-01 | Huiru Wang | Glycan-based drugs, therapies and biomarkers |
US8496946B2 (en) | 2011-03-10 | 2013-07-30 | International Business Machines Corporation | Antimicrobial hydrogels, methods of preparation thereof, and articles therefrom |
US9642916B2 (en) | 2012-12-12 | 2017-05-09 | The Regents Of The University Of California | Porphyrin modified telodendrimers |
BR112015019598B1 (pt) | 2013-02-19 | 2020-06-23 | Johnson & Johnson Consumer Inc. | Métodos para aprimorar a aparência de e/ou reduzir substancialmente a formação de cicatrizes e outros efeitos visíveis de feridas curadas, quelóides e cicatrizes hipertróficas |
CN109743890B (zh) * | 2016-06-12 | 2021-01-15 | 阵列科技股份有限公司 | 夹式安装导轨,安装支架,以及安装太阳能模块的方法 |
EP3478233B1 (de) * | 2016-06-30 | 2021-06-09 | Safkan, Inc. | Am körper tragbarer ohrreiniger |
WO2018053316A1 (en) | 2016-09-15 | 2018-03-22 | The Regents Of The University Of California | Improved hybrid telodendrimers |
US20210330701A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant |
US20210330806A1 (en) * | 2020-04-23 | 2021-10-28 | Johnson & Johnson Consumer Inc. | Methods and compositions inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers |
WO2022271183A1 (en) * | 2021-06-25 | 2022-12-29 | Allexcel Inc. | Self-assembling amphphlic polymers as anti-covid-19 agents |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998026662A1 (en) * | 1996-12-19 | 1998-06-25 | The Penn State Research Foundation | Compounds and methods for treating and preventing bacterial and viral disease |
WO2006034081A2 (en) * | 2004-09-17 | 2006-03-30 | Massachusetts Institute Of Technology | Polymers for analyte detection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1063254A1 (de) * | 1999-06-25 | 2000-12-27 | Technische Uni München, Klinikum rechts der Isar, Inst. für Experiment. Onkoligie und Therapieforschung | Copolymere für den Transport von Nukleinsäuren in die Zelle |
CA2558767A1 (en) * | 2004-07-06 | 2006-01-12 | Warwick Effect Polymers Limited | Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates anddrugs obtained therefrom |
ES2523431T3 (es) | 2006-01-19 | 2014-11-25 | Allexcel, Inc. | Solubilización y suministro dirigido de fármacos con polímeros anfifílicos de autoensamblaje |
-
2007
- 2007-01-22 WO PCT/US2007/001607 patent/WO2008091246A1/en active Application Filing
- 2007-01-22 AU AU2007344657A patent/AU2007344657B9/en not_active Ceased
- 2007-01-22 EP EP07716870.6A patent/EP2120974B1/de active Active
- 2007-01-22 KR KR1020097011410A patent/KR101405764B1/ko active IP Right Grant
- 2007-01-22 CA CA2676239A patent/CA2676239C/en active Active
- 2007-01-22 HU HUE07716870A patent/HUE034416T2/en unknown
- 2007-01-22 BR BRPI0719561-3A patent/BRPI0719561A2/pt not_active IP Right Cessation
- 2007-01-22 US US12/518,411 patent/US20100008938A1/en not_active Abandoned
- 2007-01-22 EA EA200900685A patent/EA026125B1/ru not_active IP Right Cessation
- 2007-01-22 CN CN200780050316.XA patent/CN101636169B/zh not_active Expired - Fee Related
- 2007-01-22 AP AP2009004861A patent/AP2523A/xx active
- 2007-01-22 MX MX2009005345A patent/MX2009005345A/es active IP Right Grant
- 2007-01-22 JP JP2009546355A patent/JP5539733B2/ja not_active Expired - Fee Related
- 2007-01-22 NZ NZ576948A patent/NZ576948A/en not_active IP Right Cessation
-
2009
- 2009-05-20 IL IL198850A patent/IL198850A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998026662A1 (en) * | 1996-12-19 | 1998-06-25 | The Penn State Research Foundation | Compounds and methods for treating and preventing bacterial and viral disease |
WO2006034081A2 (en) * | 2004-09-17 | 2006-03-30 | Massachusetts Institute Of Technology | Polymers for analyte detection |
Non-Patent Citations (3)
Title |
---|
ITOH M. ET AL.: 'Suppression of Influenza Virus Infection by an N-Thioacetylneuramine Acid Acrylamide Copolymer Resistant to Neuraminidase' VIROLOGY vol. 212, 1995, pages 340 - 347, XP002036922 * |
MYUNG GI-BAEK ET AL.: 'Design and Synthesis of Novel Glycopolythiophene Assemblies for Colorimetric Detection of Influenza Virus and E. coli' BIOCONJUGATE CHEMISTRY vol. 11, 2000, pages 777 - 788, XP008110959 * |
REUTER J D ET AL: "INHIBITION OF VIRAL ADHESION AND INFECTION BY SIALIC-ACID- CONJUGATED DENDRITIC POLYMERS", BIOCONJUGATE CHEMISTRY, ACS, WASHINGTON, DC, US, vol. 10, no. 2, 1 March 1999 (1999-03-01), pages 271-278, XP000804253, ISSN: 1043-1802, DOI: 10.1021/BC980099N * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001244567B2 (en) * | 2001-03-27 | 2006-04-27 | National Institute Of Agrobiological Sciences | Vegetative growth-specific promoter and genetically modified plants obtained thereby |
Also Published As
Publication number | Publication date |
---|---|
AU2007344657B2 (en) | 2014-01-30 |
NZ576948A (en) | 2010-12-24 |
KR20100014255A (ko) | 2010-02-10 |
HUE034416T2 (en) | 2018-02-28 |
IL198850A (en) | 2017-08-31 |
EA026125B1 (ru) | 2017-03-31 |
BRPI0719561A2 (pt) | 2013-01-29 |
CA2676239A1 (en) | 2008-07-31 |
AP2009004861A0 (en) | 2009-06-30 |
EA200900685A1 (ru) | 2010-02-26 |
EP2120974A1 (de) | 2009-11-25 |
EP2120974A4 (de) | 2012-11-21 |
CN101636169A (zh) | 2010-01-27 |
US20100008938A1 (en) | 2010-01-14 |
JP5539733B2 (ja) | 2014-07-02 |
EP2120974B1 (de) | 2017-03-01 |
JP2010516673A (ja) | 2010-05-20 |
WO2008091246A1 (en) | 2008-07-31 |
IL198850A0 (en) | 2010-02-17 |
KR101405764B1 (ko) | 2014-06-10 |
CN101636169B (zh) | 2014-05-07 |
AU2007344657A1 (en) | 2008-07-31 |
MX2009005345A (es) | 2009-06-12 |
CA2676239C (en) | 2016-06-21 |
AU2007344657B9 (en) | 2014-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1224232A1 (zh) | 作爲抗癌劑的自組裝的兩親性聚合物 | |
AP2523A (en) | Self-assembling amphiphilic polymers as antiviral agents | |
GB0815968D0 (en) | Antiviral agents | |
GB0709791D0 (en) | Antiviral agents | |
IL207826A0 (en) | Antiviral therapeutic agents | |
IL211147A0 (en) | 1h-benzimidazole-5-carboxamides as anti-inflammatory agents | |
EP2219587A4 (de) | Sterol-modifizierte amphiphile lipide | |
ZA201001576B (en) | Catalyst compositions | |
EP2146644A4 (de) | Chirurgischer retraktor | |
BRPI0917773A2 (pt) | "membro antiviral" | |
EP2235068A4 (de) | Selbstorganisierter olefinpolymerisationskatalysator | |
GB0707000D0 (en) | Antiviral agents | |
EP2207824A4 (de) | Thermoplastische amphiphile co-vernetzungen | |
IL210207A0 (en) | Compounds having antiviral properties | |
IL209602A0 (en) | Amphiphilic branched polymers and their use as emulsifiers | |
EP2297218A4 (de) | Amphiphile blockcopolymerformulierungen | |
GB2456407B (en) | Polymer compositions | |
HK1156246A1 (en) | Antiviral patch | |
GB0805264D0 (en) | Antiviral agents | |
GB0803707D0 (en) | Antiviral agent | |
EP2206631A4 (de) | Seitenairbag | |
EP2137031A4 (de) | Airbag | |
EP2209817A4 (de) | Viruzidzusammensetzungen | |
EP2127675A4 (de) | Antivirales mittel | |
PL2192861T3 (pl) | Retraktor chirurgiczny |